Drug · DIN 02355655
RESTASIS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 5, 2024; first marketed September 29, 2010.
- Drug Identification Number (DIN)
- 02355655
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Emulsion
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Ciclosporin S01XA18
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CYCLOSPORINE | 0.05 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 8, 2022: NOC 28712New Drug Submission (NDS) · Administrative: Merger/Buy-out
- August 19, 2010: NOC 11673New Drug Submission (NDS)